Cargando…
Current and future treatment strategies in chronic lymphocytic leukemia
Treatment decisions for patients with chronic lymphocytic leukemia (CLL) are dependent on symptoms and classification into high-, medium-, or low-risk categories. The prognosis for CLL hinges, in part, on the presence or absence of less-favorable genetic aberrations, including del(17p), del(11q), TP...
Autores principales: | Patel, Krish, Pagel, John M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074228/ https://www.ncbi.nlm.nih.gov/pubmed/33902665 http://dx.doi.org/10.1186/s13045-021-01054-w |
Ejemplares similares
-
PI3K Inhibitors for the Treatment of Chronic Lymphocytic Leukemia: Current Status and Future Perspectives
por: Hus, Iwona, et al.
Publicado: (2022) -
Current concepts in diagnosis and treatment of chronic lymphocytic leukemia
por: Hus, Iwona, et al.
Publicado: (2015) -
The Role of Bruton’s Kinase Inhibitors in Chronic Lymphocytic Leukemia: Current Status and Future Directions
por: Robak, Tadeusz, et al.
Publicado: (2022) -
Atypical Chronic Lymphocytic Leukemia—The Current Status
por: Robak, Tadeusz, et al.
Publicado: (2023) -
New Insights into Biology, Prognostic Factors, and Current Therapeutic Strategies in Chronic Lymphocytic Leukemia
por: Smolewski, Piotr, et al.
Publicado: (2013)